Clinical researcher in the Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec and in the Department of Family Medicine and Emergency Medicine at Laval University in Quebec.
Professor Emeritus in the Department of Family Medicine and Emergency Medicine at Laval University.
Can Fam Physician. 2018 Dec;64(12):e531-e539.
To determine the existence and the level of health care professional (HCP) knowledge of local policies regarding drug sample use and the relationship between residents and the pharmaceutical industry in academic primary health care settings.
Descriptive cross-sectional survey. Health care providers were invited to complete a self-administered questionnaire on drug sample use between February and December 2013. Managers of drug samples were also asked to complete a specific questionnaire on drug sample management and policies and an inventory log sheet. Data about the existence of written policies were validated with health and social services centre (HSCC) directors or pharmacy departments and family medicine teaching unit (FMTU) directors between February and June 2014.
All 42 FMTUs in Quebec.
All HCPs in the FMTUs authorized to hand out drug samples (practising physicians, residents, pharmacists, and nurses). were defined as those who reported using drug samples. were defined as HCPs or staff members who managed drug samples.
Existence of written policies on drug sample use in HSCCs and FMTUs; whether FMTUs applied the HSCC policies if they existed; whether dispensers were aware of the existence of the policies; and whether policies on the relationships between residents and pharmaceutical companies existed.
Among the 42 FMTUs, 33 (79%) kept drug samples. Of these, 30% (10 of 33) did not have policies about drug samples in the FMTU or in the HSCC. A total of 67% (579 of 859) of HCPs from these FMTUs reported using drug samples. Most dispensers did not know if a policy existed in their FMTU (n = 297; 51%) or their HSCC (n = 420; 73%). Eleven (26%) of the 42 FMTU directors reported having a policy regarding relationships between residents and the pharmaceutical industry. Most drug sample dispensers were not aware whether such a policy existed (n = 310; 54%).
Many FMTUs did not have policies regarding drug samples or relationships between residents and the pharmaceutical industry. Variation in use and management of drug samples and the lack of knowledge of HCPs about the existence of policies point to the need to implement uniform policies in all FMTUs in Quebec.
确定在学术基层医疗保健环境中,医疗保健专业人员(HCP)对当地药品样本使用政策的了解程度和居民与制药业的关系的存在和水平。
描述性的横断面调查。邀请医疗保健提供者在 2013 年 2 月至 12 月期间填写一份关于药品样本使用的自我管理问卷。药品样本管理人员还被要求填写一份关于药品样本管理和政策的具体问卷以及库存记录单。关于书面政策存在的数据,通过 2014 年 2 月至 6 月期间与卫生和社会服务中心(HSCC)主任或药剂科主任以及家庭医学教学单位(FMTU)主任进行验证。
魁北克的所有 42 个 FMTU。
授权分发药品样本的 FMTU 中的所有 HCP(执业医师、住院医师、药剂师和护士)。 被定义为报告使用药品样本的 HCP。 被定义为管理药品样本的 HCP 或工作人员。
HSCC 和 FMTU 中关于药品样本使用的书面政策的存在;如果存在政策,FMTU 是否适用;药剂师是否了解政策的存在;以及是否存在关于居民与制药公司关系的政策。
在 42 个 FMTU 中,有 33 个(79%)保留了药品样本。其中,30%(10/33)在 FMTU 或 HSCC 中没有药品样本政策。来自这些 FMTU 的总共 67%(859 名中的 579 名)的 HCP 报告使用了药品样本。大多数分发者不知道他们的 FMTU(n = 297;51%)或他们的 HSCC(n = 420;73%)是否存在政策。42 个 FMTU 主任中有 11 个(26%)报告制定了居民与制药业关系政策。大多数药品样本分发者不知道是否存在此类政策(n = 310;54%)。
许多 FMTU 没有关于药品样本或居民与制药业关系的政策。药品样本使用和管理的差异以及 HCP 对政策存在的认识不足,表明需要在魁北克的所有 FMTU 中实施统一政策。